BIOCAN PUPPY, liofilizatas ir suspensija injekcinei suspensijai ruošti šunims
BIOCAN PUPPY, liofilizatas ir suspensija injekcinei suspensijai ruošti šunims
Authorised
- Canine distemper virus, Live
- Canine parvovirus, Inactivated
Product identification
Medicine name:
BIOCAN PUPPY, liofilizatas ir suspensija injekcinei suspensijai ruošti šunims
Active substance:
- Canine distemper virus, Live
- Canine parvovirus, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, Live15848.90tissue culture infective dose 501.00Dose
-
Canine parvovirus, Inactivated4096.00haemagglutinating units1.00Dose
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AH
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- SFVS
Authorisation number:
- LT/2/03/1546/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1546.pdf
Lithuanian (PDF)
Download Published on: 1/09/2022
How useful was this page?: